Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas

PURPOSES: SMAD4/DPC4 mutations have been associated with aggressive behavior in pancreatic ductal adenocarcinomas (PDAC), and it has recently been suggested that RUNX3 expression combined with SMAD4 status may predict the metastatic potential of PDACs. We evaluated the prognostic utility of SMAD4/RU...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yangkyu, Lee, Hyejung, Park, Hyunjin, Kim, Jin-Won, Hwang, Jin-Hyeok, Kim, Jaihwan, Yoon, Yoo-Seok, Han, Ho-Seong, Kim, Haeryoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652736/
https://www.ncbi.nlm.nih.gov/pubmed/29100342
http://dx.doi.org/10.18632/oncotarget.20815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652736/
https://www.ncbi.nlm.nih.gov/pubmed/29100342
http://dx.doi.org/10.18632/oncotarget.20815

Ejemplares similares